A Trial to Investigate the Effectiveness of Testosterone Treatment in Men With Multiple Sclerosis

Summary

This is a multicenter, prospective, placebo-controlled, double-blind randomized Phase II clinical trial assessing the effect of testosterone treatment vs. placebo treatment for 96 weeks duration on whole brain atrophy in men with MS.

Timeline

Start

—

Primary completion

2099-01

Completion

2099-01

Drugs

Indications